Reporter Sept 13 2013

September 4, 2019

Kohl’s grant supports child passenger safety initiative at Children’s Hospital

By Jessica Pasley
September 18, 2013

Fishing for new anti-cancer drugs

Vanderbilt investigators used an in vivo screen in zebrafish to identify a potential new anti-cancer drug.

By Leigh MacMillan
September 16, 2013

Mapping brain membrane proteins

New mass spectrometry imaging methods will enable studies of the distribution and identification of membrane proteins directly within tissues.

By Leigh MacMillan
September 13, 2013

Cancer nanomedicines on target

Therapeutic nanoparticles may offer a powerful new way to image and treat cancer at the same time.

By Leigh MacMillan
Deciphering DNA code
September 12, 2013

VU study identifies DNA changes in drug-resistant cancer cells

Vanderbilt investigators have combined next-generation sequencing technologies and bioinformatics analyses to screen for genome-wide genetic mutations associated with drug resistance in a series of lung cancer cell lines.

By Leigh MacMillan
lungs
September 12, 2013

Federal grant bolsters pulmonary fibrosis research

Lisa Young, M.D., associate professor of Pediatrics and Medicine and Cell Biology, has been awarded a five-year, $1.9 million National Institutes of Health grant to study what causes cellular dysfunction and pulmonary fibrosis in patients with Hermansky-Pudlak syndrome (HPS).

By Christina Echegaray
September 12, 2013

New rounds series focuses on supporting caregivers

Bedside Matters, a new hourlong, monthly rounds geared toward helping all Vanderbilt University Medical Center health care providers deal with the social and emotional issues of caring for patients and families, will begin this month.
By Nancy Humphrey
September 12, 2013

VU tracking drug’s ability to prevent type 1 diabetes

Vanderbilt’s Eskind Diabetes Clinic has been selected to examine the ability of the drug abatacept to prevent type 1 diabetes (T1D). As part of the TrialNet consortium, Vanderbilt will be one of 14 North American sites observing the effects of the drug in people at high risk to develop T1D.
By VUMC News and Communications
September 12, 2013

Two named to National Academies’ advisory board

Vanderbilt University’s Roger D. Cone, Ph.D., and Elizabeth Heitman, Ph.D., have been appointed to the National Academies’ Board on Life Sciences, which advises the government and scientific community on a wide range of topics, from stem cell research to bioterrorism.
By Bill Snyder
September 12, 2013

Discovery lecturer to discuss genetic information’s challenges

Wylie Burke, M.D., Ph.D., an expert in the social, ethical and policy implications of genetic information, will deliver the next Flexner Discovery Lecture on Thursday, Sept. 19.
By Leigh MacMillan
September 12, 2013

Champ’s Corner Store open for business

Building on an already successful venture to offer a variety of safety products to patients and families, the Monroe Carell Jr. Children’s Hospital at Vanderbilt has expanded its Safety Store to become Champ’s Corner Store.
By Christina Echegaray
September 12, 2013

Sleep education helps families of children with autism

Parent sleep education is beneficial in improving sleep and aspects of daytime behavior and family functioning in children with autism spectrum disorders (ASD), according to a Vanderbilt study published in the Journal of Autism and Developmental Disorders.
By Craig Boerner
September 12, 2013

Nobel laureate Beutler to speak at VU Sept. 23

Nobel laureate Bruce Beutler, M.D., will discuss his research on innate immunity during a noon seminar Monday, Sept. 23, in 208 Light Hall.
By Bill Snyder